Cargando…

The impacts of implementation of National Essential Medicines Policies on primary healthcare institutions: a cross-sectional study in China

BACKGROUND: In 2009, China implemented the National Essential Medicines Policies (NEMPs) as part of a new round of medical system reforms. This study aims to evaluate the impacts of the NEMPs on primary healthcare institutions and discuss the roles of the policies in the new healthcare reforms of Ch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Zhigang, Guan, Xiaodong, Shi, Luwen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683609/ https://www.ncbi.nlm.nih.gov/pubmed/29132361 http://dx.doi.org/10.1186/s12913-017-2698-x

Ejemplares similares

Effect of the full coverage policy of essential medicines on medication adherence: A quasi-experimental study in Taizhou, China
por: Guo, Zhigang, et al.
Publicado: (2022)

Effects of the Full Coverage Policy of Essential Medicines on Inequality in Medication Adherence: A Longitudinal Study in Taizhou, China
por: Guo, Zhigang, et al.
Publicado: (2022)

Factors Associated with Free Medicine Use in Patients with Hypertension and Diabetes: A 4-Year Longitudinal Study on Full Coverage Policy for Essential Medicines in Taizhou, China
por: Guo, Zhigang, et al.
Publicado: (2021)

The Impact of the National Essential Medicines Policy on Rational Drug Use in Primary Care Institutions in Jiangsu Province of China
por: CHAO, Jianqian, et al.
Publicado: (2018)

Antibiotic use and irrational antibiotic prescriptions in 66 primary healthcare institutions in Beijing City, China, 2015–2018
por: Taxifulati, Yumiti, et al.
Publicado: (2021)

Outpatient prescribing pattern for acute bronchitis in primary healthcare settings in China
por: Fu, Mengyuan, et al.
Publicado: (2021)

An analysis on rational use and affordability of medicine after the implementation of National Essential Medicines Policy and Zero Mark-up Policy in Hangzhou, China
por: Mao, Wenhui, et al.
Publicado: (2019)

Prices and Clinical Benefit of National Price-Negotiated Anticancer Medicines in China
por: Zhang, Yichen, et al.
Publicado: (2022)

Appropriate use of antibiotics for acute respiratory infections at primary healthcare facilities in China: a nationwide cross-sectional study from 2017 to 2019
por: Fu, Mengyuan, et al.
Publicado: (2023)

A survey of availability, price and affordability of essential medicines from 2011 to 2016 in Chinese secondary and tertiary hospitals
por: Guan, Xiaodong, et al.
Publicado: (2018)

Evaluating the Price, Availability, and Affordability of Essential Medicines in Primary Healthcare Institutions: A Mixed Longitudinal and Cross-Sectional Study in Jiangsu, China
por: Wang, Xiao, et al.
Publicado: (2022)

Outpatient Antibiotic Prescribing Patterns and Appropriateness for Children in Primary Healthcare Settings in Beijing City, China, 2017–2019
por: Wushouer, Haishaerjiang, et al.
Publicado: (2021)

Psychotropic medication utilisation in adult cancer patients in China: A cross-sectional study based on national health insurance database
por: Bai, Lin, et al.
Publicado: (2020)

Medication Use During Pregnancy in Mainland China: A Cross-Sectional Analysis of a National Health Insurance Database
por: Zhang, Jingyuan, et al.
Publicado: (2019)

The impact of government reimbursement negotiation on targeted anticancer medicines use and cost in China: A cohort study based on national health insurance data
por: Yang, Yu, et al.
Publicado: (2023)

Evaluation of prescription review and feedback policy on rational antibiotic use in primary healthcare settings in Beijing, China: a qualitative study using the Theoretical Domains Framework and the behaviour change wheel
por: Wushouer, Haishaerjiang, et al.
Publicado: (2023)

Protocol of a tailored educational intervention for general practitioners on potentially inappropriate medications among older patients at community healthcare institutions in Beijing, China: a cluster-randomised controlled trial
por: Fu, Mengyuan, et al.
Publicado: (2021)

The Effect of China’s National Essential Medicine Policy on Health Expenses: Evidence From a National Study
por: Li, Qian, et al.
Publicado: (2018)

Evidence of clinical benefit of WHO essential anticancer medicines for children, 2011–2021
por: Bai, Lin, et al.
Publicado: (2023)

Patients' Willingness of First Visit in Primary Medical Institutions and Policy Implications: A National Cross-Sectional Survey in China
por: Li, Jin, et al.
Publicado: (2022)

Safety of medication use during pregnancy in mainland China: based on a national health insurance database in 2015
por: Zhang, Jingyuan, et al.
Publicado: (2019)

The Impact of Sanming Healthcare Reform on Antibiotic Appropriate Use in County Hospitals in China
por: Hu, Lin, et al.
Publicado: (2022)

Primary healthcare policy implementation in South Asia
por: van Weel, Chris, et al.
Publicado: (2016)

Medical insurance and healthcare utilization among the middle-aged and elderly in China: evidence from the China health and retirement longitudinal study 2011, 2013 and 2015
por: Zhou, Yue, et al.
Publicado: (2020)

Overall survival benefits of cancer drugs in the WHO Model List of Essential Medicines, 2015–2021
por: Zhou, Yue, et al.
Publicado: (2023)

The Effect of the Full Coverage of Essential Medicines Policy on Utilization and Accessibility of Primary Healthcare Service for Rural Seniors: A Time Series Study in Qidong, China
por: Wang, Ying, et al.
Publicado: (2019)

Effectiveness of hierarchical medical system policy: an interrupted time series analysis of a pilot scheme in China
por: Hu, Huajie, et al.
Publicado: (2023)

Anticancer medicines in China: Trends in daily therapy cost and relative procurement volume and spending
por: Huang, Tao, et al.
Publicado: (2021)

Health Care Utilization and Costs of Patients With Prostate Cancer in China Based on National Health Insurance Database From 2015 to 2017
por: Bai, Lin, et al.
Publicado: (2020)

National Essential Medicines List and policy practice: A case study of China’s health care reform
por: Tian, Xin, et al.
Publicado: (2012)

Distribution of essential medicines to primary care institutions in Hubei of China: effects of centralized procurement arrangements
por: Yang, Lianping, et al.
Publicado: (2017)

Institutional rules for framing healthcare policy issues in national, financial, and specialized newspapers
por: Park, Kisoo, et al.
Publicado: (2015)

A study of implementation of national language policies in a local higher institution: a case study from China
por: Chen, Xiaorui
Publicado: (2016)

Does providing more services increase the primary hospitals’ revenue? An assessment of national essential medicine policy based on 2,675 counties in China
por: Chen, Fei, et al.
Publicado: (2018)

Trends of Negotiated Targeted Anticancer Medicines Use in China: An Interrupted Time Series Analysis
por: Huang, Cong, et al.
Publicado: (2021)

WHO Essential Medicines Policies and Use in Developing and Transitional Countries: An Analysis of Reported Policy Implementation and Medicines Use Surveys
por: Holloway, Kathleen Anne, et al.
Publicado: (2014)

Attitudes and Response Capacities for Public Health Emergencies of Healthcare Workers in Primary Healthcare Institutions: A Cross-Sectional Investigation Conducted in Wuhan, China, in 2020
por: Tang, Changmin, et al.
Publicado: (2022)

Benzodiazepine Receptor Agonists Prescribing for Insomnia Among Adults in Primary Health Care Facilities in Beijing, China
por: Fu, Mengyuan, et al.
Publicado: (2023)

Sponsorship bias in published pharmacoeconomic evaluations of national reimbursement negotiation drugs in China: a systematic review
por: He, Zixuan, et al.
Publicado: (2023)

Current perspectives on China’s national essential medicine system: primary care provider and patient views
por: Song, Yan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_na3kkmmj48aphe29hn24ipoaau